Humana (NYSE:HUM) Upgraded at Wall Street Zen

by · The Cerbat Gem

Wall Street Zen upgraded shares of Humana (NYSE:HUM – Free Report) from a hold rating to a buy rating in a research note published on Friday morning.

Several other research analysts have also issued reports on HUM. Raymond James Financial raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $315.00 target price on the stock in a research note on Thursday, May 1st. Robert W. Baird raised their target price on shares of Humana from $270.00 to $300.00 and gave the company a “neutral” rating in a research note on Tuesday, April 15th. Mizuho raised their target price on shares of Humana from $305.00 to $316.00 and gave the company an “outperform” rating in a research note on Wednesday, April 9th. Guggenheim assumed coverage on shares of Humana in a research note on Wednesday, April 9th. They issued a “buy” rating and a $326.00 target price on the stock. Finally, Oppenheimer raised their target price on shares of Humana from $300.00 to $310.00 and gave the company an “outperform” rating in a research note on Thursday, May 1st. Sixteen equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, Humana has a consensus rating of “Hold” and a consensus target price of $280.76.

Read Our Latest Stock Analysis on Humana

Humana Stock Up 0.8%

Shares of NYSE:HUM opened at $241.82 on Friday. Humana has a 12 month low of $212.45 and a 12 month high of $406.46. The company’s 50-day moving average price is $241.94 and its two-hundred day moving average price is $259.20. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.71. The firm has a market cap of $29.18 billion, a P/E ratio of 17.10, a P/E/G ratio of 1.82 and a beta of 0.43.

Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, topping analysts’ consensus estimates of $10.07 by $1.51. Humana had a net margin of 1.42% and a return on equity of 14.47%. The firm had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. During the same quarter in the prior year, the firm earned $7.23 EPS. The company’s revenue was up 8.4% on a year-over-year basis. As a group, research analysts forecast that Humana will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 annualized dividend and a yield of 1.46%. Humana’s dividend payout ratio (DPR) is currently 25.04%.

Institutional Trading of Humana

Several hedge funds have recently bought and sold shares of HUM. Revolve Wealth Partners LLC acquired a new stake in Humana during the 4th quarter worth approximately $202,000. Atria Wealth Solutions Inc. raised its holdings in Humana by 21.1% during the 4th quarter. Atria Wealth Solutions Inc. now owns 1,610 shares of the insurance provider’s stock worth $409,000 after buying an additional 281 shares during the period. Sigma Planning Corp raised its holdings in Humana by 122.0% during the 4th quarter. Sigma Planning Corp now owns 1,456 shares of the insurance provider’s stock worth $369,000 after buying an additional 800 shares during the period. Oregon Public Employees Retirement Fund raised its holdings in Humana by 0.6% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 10,316 shares of the insurance provider’s stock worth $2,617,000 after buying an additional 62 shares during the period. Finally, New York Life Investment Management LLC raised its holdings in Humana by 1.1% during the 4th quarter. New York Life Investment Management LLC now owns 18,049 shares of the insurance provider’s stock worth $4,579,000 after buying an additional 205 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Company Profile

(Get Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Articles